Thu, Jul 31, 2014, 3:14 AM EDT - U.S. Markets open in 6 hrs 16 mins

Recent

% | $
Click the to save as a favorite.

Genomic Health Inc. Message Board

KD_107 2 posts  |  Last Activity: 15 hours ago Member since: Jan 22, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I saw that, in a no-news month, at that... I may be wrong, but I think I may be somewhat responsible for this massive jump in shares shorted.

    here's how: In May we signed a contract to buy a really nice property, with a firm closing date of July 11. My intention was to sell some of my NSTG to buy the property, however I kept postponing the sale, waiting for some rally on the Celgene news. Didn't work out, so on July 5 and 6th I needed to sell or we would have lost the property and the deposit. I am not talking massive amounts, but with a thinly-traded stock some 20,000 offered at market can really move the price...

    It was unpleasant to see how my selling precipitated a dump, but also somewhat amusing. Maybe some shorters saw my somewhat panicked selling and decided that some smart money is dumping stock, and decided to pound on it. Or may it was sensed by a computer trading program. The point is, I have the sale receipts to show that I initiated the stock decline... from there, who knows what happened...

  • Reply to

    ER next week...

    by soflaturtle Apr 30, 2014 1:17 PM
    kd_107 kd_107 May 12, 2014 9:46 PM Flag

    Yes, you're correct. Here's to illustrate your point:
    http://finance.yahoo.com/q/ta?s=FLDM&t=1y&l=on&z=l&q=l&p=&a=&c=nstg

    All price movement lately is sector specific. Over the long term, NSTG should outperform FLDM, because it has higher organic growth and lower P/S valuation. FLDM growth is due to acquisition, which diluted the share count. I haven't sold yet, either.

    Sentiment: Buy

GHDX
26.35+0.14(+0.53%)Jul 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.